The Society of Hematologic Oncology (SOHO) has announced a new a four-hour, live, CME-certified, presession Clinical Success Workshop titled, "The Evolving Landscape of Anemia in MDS & MPNs: Clinical ...

The impact of physical and nutritional rehabilitation post bone marrow transplant in patients with hematologic malignancies ...

The poster presented data from AUTX-703, a potent, selective and orally bioavailable heterobifunctional degrader of KAT2A/B, an AURIGIN-identified histone acetyltransferase driving small cell lung ...

Caspian Oliai, MD, MS, medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center, discusses ...

Bispecific antibodies have become component in the arsenal of treatments for hematologic malignancies; management of their side effects is crucial to their success.

The National Comprehensive Cancer Network (NCCN)—an alliance of leading cancer centers—celebrated 30 years of helping people ...

Deputy directors at the FDA center that oversees the regulation of cancer drugs plan to leave, adding to a flood of top ...

Cancer patients may have an increased risk of developing second primary malignancies after immune checkpoint inhibitor therapy.

A review of the side effects of CAR T-cell therapy, including CRS, ICANS, tumor lysis syndrome, and late-onset toxicities, and management strategies.

Marker Therapeutics is advancing a unique multi antigen recognizing (MAR)-T cell therapy platform designed to target multiple tumor-associated antigens simultaneously, an approach that has shown ...